[go: up one dir, main page]

NO980688D0 - Sammenföyde isoquinoliner som dopamin-reseptor-ligander - Google Patents

Sammenföyde isoquinoliner som dopamin-reseptor-ligander

Info

Publication number
NO980688D0
NO980688D0 NO980688A NO980688A NO980688D0 NO 980688 D0 NO980688 D0 NO 980688D0 NO 980688 A NO980688 A NO 980688A NO 980688 A NO980688 A NO 980688A NO 980688 D0 NO980688 D0 NO 980688D0
Authority
NO
Norway
Prior art keywords
receptor ligands
isoquinolines
joining
dopamine receptor
compounds
Prior art date
Application number
NO980688A
Other languages
English (en)
Other versions
NO980688L (no
NO308658B1 (no
Inventor
David E Nichols
Richard Mailman
Debasis Ghosh
Original Assignee
Purdue Research Foundation
Univ North Carolina
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Purdue Research Foundation, Univ North Carolina filed Critical Purdue Research Foundation
Publication of NO980688L publication Critical patent/NO980688L/no
Publication of NO980688D0 publication Critical patent/NO980688D0/no
Publication of NO308658B1 publication Critical patent/NO308658B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04Ortho- or peri-condensed ring systems
    • C07D221/18Ring systems of four or more rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
NO980688A 1995-08-18 1998-02-18 Sammenføyde isoquinoliner som dopamin-reseptor-ligander NO308658B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US251995P 1995-08-18 1995-08-18
PCT/US1996/013416 WO1997006799A1 (en) 1995-08-18 1996-08-16 Novel fused isoquinolines as dopamine receptor ligands

Publications (3)

Publication Number Publication Date
NO980688L NO980688L (no) 1998-02-18
NO980688D0 true NO980688D0 (no) 1998-02-18
NO308658B1 NO308658B1 (no) 2000-10-09

Family

ID=21701148

Family Applications (1)

Application Number Title Priority Date Filing Date
NO980688A NO308658B1 (no) 1995-08-18 1998-02-18 Sammenføyde isoquinoliner som dopamin-reseptor-ligander

Country Status (18)

Country Link
US (2) US5959110A (no)
EP (1) EP0845988B1 (no)
JP (1) JP2000505046A (no)
CN (1) CN1199338A (no)
AT (1) ATE209915T1 (no)
AU (1) AU700688B2 (no)
BR (1) BR9610323A (no)
CA (1) CA2227585A1 (no)
DE (1) DE69617700T2 (no)
DK (1) DK0845988T3 (no)
ES (1) ES2169257T3 (no)
IL (1) IL122974A (no)
MX (1) MX9801179A (no)
NO (1) NO308658B1 (no)
NZ (1) NZ316312A (no)
PT (1) PT845988E (no)
RU (1) RU2177001C2 (no)
WO (1) WO1997006799A1 (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9610323A (pt) * 1995-08-18 1999-12-21 Perdue Research Foundation Novas isoquinolinas fundidas como ligantes de receptor de dopamina
EP1320367A4 (en) * 2000-08-11 2007-01-17 Purdue Research Foundation METHOD OF PREPARING DINAPSOLIN
JP2005504717A (ja) * 2001-01-16 2005-02-17 パーデュー・リサーチ・ファウンデーション ドーパミン関連性機能不全の治療法
JP2005504758A (ja) * 2001-08-10 2005-02-17 パーデュー・リサーチ・ファウンデーション キラル・ジナプソリン
DK1480647T3 (da) * 2002-02-15 2009-01-26 Darpharma Inc Mono-ester eller asymmetrisk substituerede di-ester-prodrugs af dopamin-D1 receptoragonister
JP2004190007A (ja) * 2002-11-27 2004-07-08 Konica Minolta Holdings Inc 色素およびインクジェット記録液
JP2007506967A (ja) * 2003-09-24 2007-03-22 ビアコーレ・アー・ベー 分子相互作用分析の方法及びシステム
EP2010541A2 (en) * 2006-02-21 2009-01-07 Purdue Research Foundation Trans-fused chromenoisoquinolines, synthesis and methods for use
RS53866B1 (sr) * 2008-07-16 2015-08-31 Richter Gedeon Nyrt. Farmaceutske formulacije koje sadrže ligande dopaminskih receptora
US9359303B2 (en) 2009-04-21 2016-06-07 Purdue Research Foundation Octahydrobenzoisoquinoline modulators of dopamine receptors and uses therefor
CN110068645B (zh) * 2019-04-03 2021-09-03 上海药明奥测医疗科技有限公司 液质联用检测尿液中环磷酸腺苷的方法
WO2021021922A1 (en) 2019-07-30 2021-02-04 Mayo Foundation For Medical Education And Research Compounds and methods for treating fibrotic pathologies
EP4284507A4 (en) * 2021-01-29 2025-01-08 Mayo Foundation for Medical Education and Research Methods of treating ocular fibrotic pathologies

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4346090A (en) * 1977-07-21 1982-08-24 Ayerst, Mckenna & Harrison Ltd. 13-Chloro-benzocycloheptapyridoisoquinolines and use as neuroleptics
HU180234B (en) * 1979-01-22 1983-02-28 Lilly Co Eli Process for producing oktahydro-pyrasolo-aracket-3,4-g-bracket closed-quinolines
DE3624607A1 (de) * 1986-07-21 1988-01-28 Boehringer Ingelheim Kg Neue tetrahydrobenzothiazolo-chinoline ihre herstellung und verwendung
US4902695A (en) * 1989-02-13 1990-02-20 Eli Lilly And Company Excitatory amino acid receptor antagonists
US5047536A (en) * 1989-03-17 1991-09-10 Purdue Research Foundation Hexahydrobenzo(A)phenanthridine compounds
IE912999A1 (en) * 1990-09-07 1992-03-11 Abbott Lab Phenanthridine compounds
CA2054569A1 (en) * 1990-11-07 1992-05-08 Masanobu Suzuki Process for preparing benzo¬c|phenanthridinium derivatives, and novel compounds prepared by said process
AU4391493A (en) * 1992-05-26 1993-12-30 Purdue Research Foundation Substituted-hexahydrobenzo(A)phenanthridines
BR9610323A (pt) * 1995-08-18 1999-12-21 Perdue Research Foundation Novas isoquinolinas fundidas como ligantes de receptor de dopamina

Also Published As

Publication number Publication date
JP2000505046A (ja) 2000-04-25
IL122974A0 (en) 1998-08-16
DE69617700D1 (de) 2002-01-17
CN1199338A (zh) 1998-11-18
AU6851396A (en) 1997-03-12
DK0845988T3 (da) 2002-04-02
US6194423B1 (en) 2001-02-27
EP0845988B1 (en) 2001-12-05
MX9801179A (es) 1998-04-30
US5959110A (en) 1999-09-28
PT845988E (pt) 2002-05-31
NO980688L (no) 1998-02-18
ATE209915T1 (de) 2001-12-15
DE69617700T2 (de) 2002-07-18
ES2169257T3 (es) 2002-07-01
WO1997006799A1 (en) 1997-02-27
RU2177001C2 (ru) 2001-12-20
AU700688B2 (en) 1999-01-14
BR9610323A (pt) 1999-12-21
CA2227585A1 (en) 1997-02-27
EP0845988A1 (en) 1998-06-10
NO308658B1 (no) 2000-10-09
NZ316312A (en) 1999-06-29
EP0845988A4 (en) 1998-11-11
IL122974A (en) 2000-11-21

Similar Documents

Publication Publication Date Title
RO115522B1 (ro) Derivaţi de indolină, procedee pentru prepararea acestora, compoziţii farmaceutice care îi conţin şi metodă de tratament
BR9810841A (pt) Inibidores de metaloprotease alicìclicos
NO980688L (no) Sammenföyde isoquinoliner som dopamin-reseptor-ligander
NO985711D0 (no) Farmas°ytikum for behandling av neurologiske og neuropsykiatriske mangler
GC0000375A (en) Benzodiazepine derivatives as gaba a receptor modulators
UA66865C2 (uk) Інденопіролокарбазоли, фармацевтична композиція, спосіб інгібування кіназної активності та спосіб лікування (варіанти)
ATE247639T1 (de) Arylsubstituierte cyclische amine als selektive dopamin-d3-liganden
ID24228A (id) (+)norcisaprida yang berguna untuk gangguan tertular 5-ht3 dan 5-ht4
DK1274685T3 (da) Et pyridin-N-oxid-derivat og fremgangsmåde til omdannelse deraf til farmaceutisk effektive forbindelser
HRP20010969B1 (en) Novel piperazinylalkylthiopyrimidine derivatives,
BR9812085A (pt) "método para a sìntese de derivados de quinolina"
DK0823909T3 (da) Hidtil ukendte heterocykliske forbindelser
ATE214375T1 (de) Piperazinylalkylthiopyrimidin derivate, diese enthaltende pharmazeutische zusammensetzungen und verfahren zu deren herstellung
PT1025101E (pt) Derivados de nafto-imidazo¬1,2-a|piridina sua preparacao e uso no tratamento de perturbacoes do sistema nervoso central
ATE243695T1 (de) 5-bicycloindolverbindungen
DE69827706D1 (de) 5-(Heteroaryl)alkyl)-3-oxo-pyrido(1,2-a)benzimidazol-4-carboxamid (PBI) Derivate zur Behandlung von Störungen des zentralen Nervensystems
NO882724D0 (no) Smertepreparat.
EA199901049A2 (ru) Спироимидазолиновые соединения, способ их получения и фармацевтическая композиция, содержащая их
DK0837680T3 (da) Anvendelse af phenoxy-pyridinderivater til behandling af sygdomme, som forårsages af forstyrrelser i dopaminsystemet
NO20014889D0 (no) Fremgangsmåte for fremstilling av medisinske midler
ATE369354T1 (de) Isochinolin-aroylpyrrole für die behandlung von krankheiten des zentralnervensystems
GR930100339A (el) Μέ?οδος για την παρασκευή δικυκλικών αμιδινουδραζονών.
SE9901338D0 (sv) Novel process